Loading...

CoroWare

OTCPK:COWI
Snowflake Description

Adequate balance sheet with weak fundamentals.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
COWI
OTCPK
$14K
Market Cap
  1. Home
  2. US
  3. Software
Company description

CoroWare, Inc., through its subsidiary, CoroWare Technologies, Inc., delivers custom engineering services, and hardware and software products in North America and Europe. The last earnings update was 1038 days ago. More info.


Add to Portfolio Compare Print
  • CoroWare has significant price volatility in the past 3 months.
COWI Share Price and Events
7 Day Returns
-99%
OTCPK:COWI
-0.4%
US IT
0.1%
US Market
1 Year Returns
-99%
OTCPK:COWI
19.7%
US IT
1.2%
US Market
COWI Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
CoroWare (COWI) -99% -99% -98% -99% -99% -99%
US IT -0.4% 3.4% 9.2% 19.7% 88.2% 109.3%
US Market 0.1% 0.6% 0.9% 1.2% 36.7% 37.9%
1 Year Return vs Industry and Market
  • COWI underperformed the IT industry which returned 19.7% over the past year.
  • COWI underperformed the Market in United States of America which returned 1.2% over the past year.
Price Volatility
Industry
5yr Volatility vs Market
Related Companies

Sorry, no analysis for CoroWare's competitors could be found in our database.

COWI Value

 Is CoroWare undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.

In this section, we usually try to help investors determine whether CoroWare is trading at an attractive price based on the cash flow it is expected to produce in the future. But as CoroWare has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis. You can see them here.

Show me the analysis anyway

INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for CoroWare. This is due to cash flow or dividend data being unavailable. The share price is $1.0E-6.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for CoroWare's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are CoroWare's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
OTCPK:COWI PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2016-06-30) in USD Not available
OTCPK:COWI Share Price ** OTCPK (2019-06-13) in USD $0
United States of America IT Industry PE Ratio Median Figure of 77 Publicly-Listed IT Companies 34.93x
United States of America Market PE Ratio Median Figure of 3,092 Publicly-Listed Companies 17.63x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of CoroWare.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to compare the PE ratio to the industry average as no data exists.
  • Unable to calculate PE ratio for CoroWare, we can't compare the value of its earnings to the United States of America market.
Price based on expected Growth
Does CoroWare's expected growth come at a high price?
Raw Data
OTCPK:COWI PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 0x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
Not available
United States of America IT Industry PEG Ratio Median Figure of 66 Publicly-Listed IT Companies 2.45x
United States of America Market PEG Ratio Median Figure of 2,126 Publicly-Listed Companies 1.53x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for CoroWare, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on CoroWare's assets?
Raw Data
OTCPK:COWI PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2016-06-30) in USD Not available
OTCPK:COWI Share Price * OTCPK (2019-06-13) in USD $0
United States of America IT Industry PB Ratio Median Figure of 128 Publicly-Listed IT Companies 4.43x
United States of America Market PB Ratio Median Figure of 5,244 Publicly-Listed Companies 1.79x

* Primary Listing of CoroWare.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to compare the PB ratio to the industry average as no data exists.

Next steps:

  1. Examine CoroWare's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
  2. Show me more potentially undervalued companies in the IT industry
  3. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Value checks
We assess CoroWare's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the IT industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the IT industry average (and greater than 0)? (1 check)
  5. CoroWare has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

COWI Future Performance

 How is CoroWare expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as CoroWare has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.

Show me the analysis anyway

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
16.9%
Expected IT industry annual growth in earnings.
Earnings growth vs Low Risk Savings
Is CoroWare expected to grow at an attractive rate?
  • Unable to compare CoroWare's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare CoroWare's earnings growth to the United States of America market average as no estimate data is available.
  • Unable to compare CoroWare's revenue growth to the United States of America market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
OTCPK:COWI Future Growth Rates Data Sources
Data Point Source Value (per year)
United States of America IT Industry Earnings Growth Rate Market Cap Weighted Average 16.9%
United States of America IT Industry Revenue Growth Rate Market Cap Weighted Average 10.3%
United States of America Market Earnings Growth Rate Market Cap Weighted Average 13.9%
United States of America Market Revenue Growth Rate Market Cap Weighted Average 7.4%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
OTCPK:COWI Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (2 years ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
OTCPK:COWI Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2016-06-30 7 0 -2
2016-03-31 6 0 -8
2015-12-31 5 0 -2
2015-09-30 4 0 -9
2015-06-30 3 0 -7
2015-03-31 2 0 -6
2014-12-31 2 0 -8
2014-09-30 2 -1 -59
2014-06-30 1 0 -62
2014-03-31 1 0 -6
2013-12-31 1 -1 -3
2013-09-30 1 0 58

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if CoroWare is high growth as no earnings estimate data is available.
  • Unable to determine if CoroWare is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
OTCPK:COWI Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (2 years ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from CoroWare Company Filings, last reported 2 years ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

OTCPK:COWI Past Financials Data
Date (Data in USD Millions) EPS *
2016-06-30 0.00
2016-03-31 0.00
2015-12-31 0.00
2015-09-30 0.00
2015-06-30 0.00
2015-03-31 0.00
2014-12-31 0.00
2014-09-30 -0.01
2014-06-30 -0.04
2014-03-31 -0.06
2013-12-31 -0.15
2013-09-30 4.98

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if CoroWare will efficiently use shareholders’ funds in the future without estimates of Return on Equity.

Next steps:

  1. Examine CoroWare's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
  2. CoroWare's future outlook can be gauged by looking at industry trends and market size, and determining how well-positioned the company is compared to its competitors. Take a look at other high-growth Software companies here
  3. While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website. If you are looking for more of a qualitative research into the company, you can access CoroWare's filings and announcements here.
  4. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Future performance checks
We assess CoroWare's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United States of America market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United States of America market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
CoroWare has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

COWI Past Performance

  How has CoroWare performed over the past 5 years?

In this section we usually display a company’s past earnings and revenues to help investors visualise the trend through time. We also gauge the company’s performance by benchmarking its returns and growth to its industry peers and the wider market. However, CoroWare has not provided sufficient past data to assess its track record.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have historical data. You can see them here.

Show me the analysis anyway

  • CoroWare's last earnings update was 1038 days ago.
The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare CoroWare's growth in the last year to its industry (IT).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Insufficient past earnings data to establish if CoroWare's year on year earnings growth rate was positive over the past 5 years.
  • Unable to compare CoroWare's 1-year growth to the 5-year average as past earnings data has not been reported.
  • Unable to compare CoroWare's 1-year growth to the US IT industry average as past earnings data has not been reported.
Earnings and Revenue History
CoroWare's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from CoroWare Company Filings, last reported 2 years ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

OTCPK:COWI Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2016-06-30 6.93 -2.10 1.23 0.14
2016-03-31 6.31 -8.31 1.29 0.15
2015-12-31 5.46 -2.31 0.93 0.15
2015-09-30 4.18 -8.54 3.53 0.12
2015-06-30 3.41 -7.16 2.89 0.09
2015-03-31 2.45 -6.48 2.69 0.11
2014-12-31 1.94 -7.94 2.47 0.11
2014-09-30 1.52 -59.34 1.76 0.10
2014-06-30 1.19 -62.18 1.67 0.08
2014-03-31 1.04 -5.90 1.58 0.04
2013-12-31 1.07 -2.65 1.76 0.02
2013-09-30 1.20 58.13 0.70 0.06
2013-06-30 1.16 54.02 0.75 0.06
2013-03-31 1.24 -2.99 0.84 0.06
2012-12-31 1.28 -3.98 0.72 0.06
2012-09-30 1.43 -5.33 1.03 0.02
2012-06-30 1.59 -1.78 1.04 0.04

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • Unable to establish if CoroWare has efficiently used shareholders’ funds last year as no Return on Equity data is available.
  • Unable to establish if CoroWare has efficiently used its assets last year compared to the US IT industry average (Return on Assets) as past financial data has not been reported.
  • Unable to establish if CoroWare improved its use of capital last year versus 3 years ago (Return on Capital Employed) due to insufficient past data.

Next steps:

  1. Examine CoroWare'sCoroWare's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
  2. While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website. If you are looking for more of a qualitative research into the company, you can access CoroWare's filings and announcements here.
  3. Past financial records are usually unavailable for companies that have just been established or recently publicly listed, which makes them inherently riskier. Take a look at a list of well-established companies here.
  4. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Past performance checks
We assess CoroWare's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the IT industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
CoroWare has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

COWI Health

 How is CoroWare's financial health and their level of debt?

In this section we usually analyse CoroWare's finance health to determine how well-positioned it is against times of financial distress, in particular, its ability to manage its cash and debt levels. CoroWare has not provided adequate balance sheet data, its financial health cannot be properly assessed as it.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have financial information. You can see them here.

Show me the analysis anyway

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up CoroWare's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Unable to compare short term assets to short term liabilities as CoroWare has not reported sufficient balance sheet data.
  • Unable to establish if CoroWare's long term commitments exceed its cash and other short term assets as CoroWare has not reported sufficient balance sheet data.
Balance sheet
This treemap shows a more detailed breakdown of CoroWare's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Unable to establish if CoroWare has a high level of physical assets or inventory without balance sheet data.
  • CoroWare has no debt, it does not need to be covered by short term assets.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from CoroWare Company Filings, last reported 2 years ago.

OTCPK:COWI Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2016-06-30 -20.70 6.07 0.06
2016-03-31 -26.66 6.09 0.00
2015-12-31 -19.55 4.40 0.10
2015-09-30 -20.00 4.61 0.05
2015-06-30 -19.55 4.46 0.02
2015-03-31 -19.09 4.31 0.06
2014-12-31 -17.32 4.18 0.03
2014-09-30 -14.28 3.87
2014-06-30 -14.80 3.91 0.00
2014-03-31 -16.95 4.28 0.00
2013-12-31 -15.70 4.43
2013-09-30 -32.11 4.61
2013-06-30 -29.75 4.69 0.00
2013-03-31 -86.38 4.38 0.01
2012-12-31 -14.82 4.13 0.00
2012-09-30 -18.45 4.74 0.00
2012-06-30 -12.12 4.37 0.00
  • CoroWare has no debt.
  • CoroWare currently has no debt however we can't compare to 5 years ago as we have no data for that period.
  • CoroWare has no debt, it does not need to be covered by operating cash flow.
  • CoroWare has no debt, therefore coverage of interest payments is not a concern.

Next steps:

  1. Investors tend to look at the financial health of a company this size in order to assess the sustainability of its current operations. While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website.
  2. Financial health is measured at one point in time, so the latest financial report is the best representation of the company’s current financial status. Check when CoroWare's financial data was last updated here.
  3. Companies with strong financial health are considered a less risky investment. Discover these stocks here.
  4. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Financial health checks
We assess CoroWare's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. CoroWare has a total score of 4/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

COWI Dividends

 What is CoroWare's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from CoroWare dividends.
If you bought $2,000 of CoroWare shares you are expected to receive $0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate CoroWare's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate CoroWare's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
OTCPK:COWI Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
United States of America IT Industry Average Dividend Yield Market Cap Weighted Average of 34 Stocks 1.3%
United States of America Market Average Dividend Yield Market Cap Weighted Average of 2011 Stocks 2.5%
United States of America Minimum Threshold Dividend Yield 10th Percentile 0.8%
United States of America Bottom 25% Dividend Yield 25th Percentile 1.5%
United States of America Top 25% Dividend Yield 75th Percentile 3.7%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as CoroWare has not reported any payouts.
  • Unable to verify if CoroWare's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of CoroWare's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as CoroWare has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess CoroWare's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can CoroWare afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. CoroWare has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

COWI Management

 What is the CEO of CoroWare's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
  • CoroWare has no CEO, or we have no data on them.
Management Team

David Hyams

TITLE
Chief Technology Officer
COMPENSATION
$99K
AGE
61
Board of Directors
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price ($) Value ($)
X
Management checks
We assess CoroWare's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. CoroWare has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

COWI News

Simply Wall St News

COWI Company Info

Description

CoroWare, Inc., through its subsidiary, CoroWare Technologies, Inc., delivers custom engineering services, and hardware and software products in North America and Europe. It offers research and development engineering services; business process workflow services; software architecture, design, and development services; content management services; console, PC, and online game production services; and marketing coordination and management services. The company’s products include CoroBot Classic, which enable customers to deploy and develop robotic solutions, as well as assist the hardware developers with physical mounting space, ports, sensors, and communication devices; and CoroBot Spark, a mobile robotics platform that supports the development of mobile robot applications that runs on Linux and Windows 10 operating systems. CoroWare, Inc., through its subsidiary, CoroWare Robotics Solutions, Inc., also offers mobile robotics, and Internet of Things products, solutions, and services for universities, government and corporate researchers, and enterprise customers. The company was formerly known as Innova Robotics & Automation, Inc. and changed its name to CoroWare, Inc. in April 2008. CoroWare, Inc. is headquartered in Bellevue, Washington.

Details
Name: CoroWare, Inc.
COWI
Exchange: OTCPK
Founded:
$13,511
13,511,776,065
Website: http://
Address: CoroWare, Inc.
601 108th Avenue Northeast,
Suite 1900,
Bellevue,
Washington, 98004,
United States
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
OTCPK COWI Common Stock Pink Sheets LLC US USD 26. Aug 2004
Number of employees
Current staff
Staff numbers
0
CoroWare employees.
Industry
IT Consulting and Other Services
Software
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/06/19 00:28
End of day share price update: 2019/06/13 00:00
Last earnings filing: 2016/08/15
Last earnings reported: 2016/06/30
Last annual earnings reported: 2015/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.